- Active discussions with FDA related to COVAXIN initiated late last year
- Master file submitted to FDA on March 26, 2021; awaiting feedback from FDA
MALVERN, Pa., May 26, 2021 … [+7247 chars]
Ocugen On Track to Submit Emergency Use Authorization – GlobeNewswire
